Searchable abstracts of presentations at key conferences in endocrinology

ea0077p195 | Metabolism, Obesity and Diabetes | SFEBES2021

Diabetes and Young COVID: A two country and two wave study of associations

Sharma Bhavna , Sharma Angelica , Sharma Indu

Authors agree that although mortality for COVID 19 is low, comorbidities may contribute to severe disease and mortality. Chinese center for disease control and prevention reported three times higher mortality in patients with diabetes. However, most studies do not take into account age of patients. Our study aimed to evaluate association of COVID in patients lesser than 65 years of age in two countries, India and United Kingdom with diabetes. We excluded patients with co-morbi...

ea0091wa13 | Workshop A: Disorders of the hypothalamus and pituitary | SFEEU2023

Dopamine agonist resistance: A prolactinoma responsive biochemically but not radiologically to cabergoline

Sharma Bhavna

The goals of treatment for a prolactinoma are to normalise serum prolactin and decrease the size of the tumour. Dopamine agonists (cabergoline is first-line) represent primary therapy for almost all prolactinomas. Some prolactinomas exhibit resistance to dopamine agonist treatment and require higher doses. Our patient was a 35-year-old male who presented to Ophthalmology in March 2021 with visual disturbance, confirmed to be secondary to a bitemporal hemianopia. OCT showed bil...

ea0091cb39 | Additional Cases | SFEEU2023

Case of Adrenocortical Tumour

Sharma Sangita

Background: Mrs X had experienced severe right sided abdominal pain. Brought to hospital by ambulance from the residential home. In Accident and Emergency, she was confused and the accuracy of her history was difficult to confirm. Mrs X had a CT abdomen and pelvis with contrast. This had reported a 3.8 cm enhancing, well defined left adrenal mass, this needed to be assessed with adrenal protocol CT. Referred to Nurse-Led Adrenal Incidentaloma clinic for investigations.<p c...

ea0077p100 | Neuroendocrinology and Pituitary | SFEBES2021

Conservative management of Cushing’s in COVID times: A case series and meta-analysis

Sharma Bhavna , Rahman Mushtaqar

We present a case series of patients admitted to our hospital with various manifestations of Cushing’s. 71 male, known type 2 diabetes, hypertension referred for adrenal incidentaloma. Cushingoid features with non suppressed ACTH. Low dose dexamethasone test (LDSST): no suppression. 4 cm pituitary microadenoma (likely co-secretory as gonadotropins elevated). Offered IPSS and pituitary surgery. Declined the same due to fears of COVID opted for medical therapy with metyrapo...

ea0055p22 | Poster Presentations | SFEEU2018

Lactotroph hyperplasia in pregnancy: An unique case of pregnancy-induced progression

Stratos Efstratos , Sharma Sanjeev

Case history & Management: A 36-year old lady of Lithuanian descent first presented in 2011 with secondary infertility due to hyperprolactinaemia of 1554 (N=0–500). Her MRI was normal and was started on Cabergoline which was stopped 5 months later when she became pregnant. She delivered normally but was thereafter lost to follow-up. She was referred back in 2014 with galactorrhoea and hyperprolactinaemia (6856) and MRI this time showed a 0.7 mm microprolactin...

ea0051p013 | Adrenal | BSPED2017

Two neonates with foetal adrenal haemorrhage in a tertiary care centre

Sharma Anu , Smit Elisa

Introduction: Foetal adrenal haemorrhage is relatively rare with a reported incidence of 0.2% in neonates. We share our experience of two neonates who were diagnosed to have adrenal haemorrhage in our centre over last 5 years. We also carried out a retrospective review of literature on existing evidence regarding diagnosis and evaluation of neonates with adrenal haemorrhage.Methodology: Two neonates with confirmed adrenal haemorrhage were identified from...

ea0081p576 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Ketosis prone type 2 diabetes in covid times - a missing link?

Sharma Bhavna , Rahman Mushtaqur

Traditional literature agrees that Diabetic Ketoacidosis is typically associated with Type 1 Diabetes Mellitus, but can be associated with stress including infections in Type 2 diabetics. The authors did a restrospective evaluation of diabetic ketoacidosis presenting to a large district hospital in London. 343 patients were admitted with diagnosis of Diabetic Ketoacidosis during the COVID peaks from January 2020 to January 2021. 57% of these were Type 1 diabetics and 43% were ...

ea0081p607 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

An audit of management of severe hyperlipidaemia in secondary and primary care services in greater london area

Sharma Bhavna , Fatima Anees

Hyperlipidaemia services in the UK are guided by National Guidance for Lipid Management for primary and secondary prevention of cardiovascular disease. Our audit studied a total of 71 patients in primary and secondary care in the greater London area with total Cholesterol levels greater than 7.5 mmols/l. In patients admitted to hospital (n=22); 27.8% patients were ITU admissions with 56% being under surgical team for acute pancreatitis. Only 45.4% of these patients we...

ea0081ep30 | Adrenal and Cardiovascular Endocrinology | ECE2022

Rare case of SIADH related hyponatremia in sarcoidosis

Sharma Bhavna , Rahman Mushtaqur

Disorders of sodium metabolism in sarcoidosis are predominated by diabetes insipidus; SIADH is extremely rare, restricted to sporadic case reports. We present the case of a 68 year old South Asian female presenting with a 3 year history of chronic, mild hyponatraemia, which was asymptomatic apart from mild lightheadedness. She had a history of stable sarcoidosis that was not requiring treatment, based on lung pathology. Despite fluid restriction, serum sodium remained around 1...

ea0082p30 | Poster Presentations | SFEEU2022

Lansoprazole induced hyperprolactinemia: Uncommon side effect of a common drug

Sharma Bhavna , Qureshi Asjid

Hyperprolactinemia is known to have a wide differential with multiple causes including physiological, pathological and pharmacological. Drug induced causes of hyperprolactinemia are myriad however these become significant when prolactin levels rise to proportions that lead to clinical manifestations. We present a case of a 40 years old lady who was referred to endocrinology for an irregular menstrual cycle. Initial investigations revealed a prolactin level of 5767 mIU/l (range...